Tositumomab/I-131 tositumomab following chemotherapy effective as first-line treatment of NHL
Oncology 18(10): 1313-1314
2004
ISSN/ISBN: 0890-9091 PMID: 15526834 Document Number: 580264
Document emailed within 1 workday
Related Documents
Sjögreen-Gleisner, K.; Dewaraja, Y.K.; Chiesa, C.; Tennvall, J.; Lindén, O.; Strand, S.E.; Ljungberg, M. 2011: Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomab Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(2): 126-154Müller, H.; Nakchbandi, V.; Chatzisavvidis, I.; von Voigt, C. 2003: Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases Hepato-Gastroenterology 50(54): 1919-1926
Rademaker, M.; Corrie, J.; Lindsay, B.A.; Flapan, A.D.; Padfield, P.L. 1989: Low dose, twice daily captopril and frusemide: a safe, effective and flexible third line treatment regimen for hypertension Journal of Human Hypertension 3(3): 173-177
Hoppe, D. 1970: The importance of chemotherapy in tumor treatment and rules for effective use in practice Das Deutsche Gesundheitswesen 25(34): 1585-1590
Caglar, K.; Ozyönüm, H.; Akalin, M.; Balci, S. 2006: Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy Turkish Journal of Pediatrics 48(4): 365-368
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Sternberg, C.N.; Yagoda, A.; Scher, H.I.; Whitmore, W.F.; Herr, H.W.; Morse, M.J.; Sogani, P.C.; Bosl, G.; Watson, R.C.; Hollander, P.S. 1988: Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy Progress in Clinical and Biological Research 260: 551-555
Inokuchi, M.; Yamashita, T.; Yamada, H.; Kojima, K.; Sekita, Y.; Kawano, T.; Sugihara, K. 2007: Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(6): 875-879
Raina, V.; Sharma, A.; Mohanti, B.K.; Kumar, R.; Dawar, R.; Rath, G.K. 2003: Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease National Medical Journal of India 16(4): 199-203
Gavrilov, V.; Steiner, M.; Shany, S. 2005: The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth Anticancer Research 25(5): 3425-3429
Saito, Y.; Kikuchi, Y.; Hayasaka, K.; Amoh, K.; Fujita, M.; Uekita, Y.; Nishino, S. 1989: Effective evaluation of combination chemotherapy in stage I-Ii of non-Hodgkin's lymphoma--a comparison of treatment with multivariate analysis Gan no Rinsho. Japan Journal of Cancer Clinics 35(7): 804-810
Castro-Rojas, C.; Ortiz-Lópezj, R.ío.; Rojas-Martínez, A. 2014: Pharmacogenomics of the first-line treatment for gastric cancer: advances in the identification of genomic biomarkers for clinical response to chemotherapy Investigacion Clinica 55(2): 185-202
Deraco, M.; Kusamura, S.; Gronchi, A. 2003: Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei Tumori 89(4 Suppl): 54-55
Kaira, K.; Ishizuka, T.; Yanagitani, N.; Sunaga, N.; Hisada, T.; Mori, M. 2007: Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 225-227
Yagi, Y.; Ichikawa, K.; Takahashi, K.; Okuda, N. 2007: A case of recurrent gastric cancer with peritoneal dissemination responding to doxifluridine/paclitaxel combination chemotherapy as third-line treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 261-263
Tachibana, T.; Matsumoto, K.; Nagi, S.; Hagiwara, M.; Kobayashi, K.; Tsumura, H.; Yoshida, K.; Iwamura, M. 2016: Combined Chemotherapy with Radiation was Tolerable and Effective Treatment in Female Octogenarian Patients with Urethral Cancer -Two Case Reports Hinyokika Kiyo. Acta Urologica Japonica 62(7): 367-371
Yoshida, T.; Mori, K.; Kamiyama, Y.; Tominaga, K. 2001: Effective combination chemotherapy using paclitaxel in the treatment of a small-cell lung cancer patient resistant to multiple drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1437-1440
Imaizumi, H.; Ishibashi, K.; Okada, N.; Tajima, Y.; Amano, K.; Hatano, S.; Kuwabara, K.; Sobajima, J.; Ishiguro, T.; Ohsawa, T.; Kumamoto, K.; Kumagai, Y.; Haga, N.; Ishida, H. 2012: Clinical outcomes in refractory colorectal cancer patients with wild-type K-ras treated with bevacizumab and oxaliplatin-based chemotherapy as a first-line treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2185-2188
Vapattanawong, P. 2006: A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer Journal of the Medical Association of Thailand 89(9): 1357-1361
Kondo, E.; Kanai, K. 1977: Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination Kekkaku: 52(8): 373-376